NaV1.8 as Proarrhythmic Target in a Ventricular Cardiac Stem Cell Model

Nico Hartmann,Maria Knierim,Wiebke Maurer,Nataliya Dybkova,Florian Zeman,Gerd Hasenfuß,Samuel Sossalla,Katrin Streckfuss-Bömeke

DOI: https://doi.org/10.3390/ijms25116144

IF: 5.6

2024-06-03

International Journal of Molecular Sciences

Abstract:The sodium channel NaV1.8, encoded by the SCN10A gene, has recently emerged as a potential regulator of cardiac electrophysiology. We have previously shown that NaV1.8 contributes to arrhythmogenesis by inducing a persistent Na+ current (late Na+ current, INaL) in human atrial and ventricular cardiomyocytes (CM). We now aim to further investigate the contribution of NaV1.8 to human ventricular arrhythmogenesis at the CM-specific level using pharmacological inhibition as well as a genetic knockout (KO) of SCN10A in induced pluripotent stem cell CM (iPSC-CM). In functional voltage-clamp experiments, we demonstrate that INaL was significantly reduced in ventricular SCN10A-KO iPSC-CM and in control CM after a specific pharmacological inhibition of NaV1.8. In contrast, we did not find any effects on ventricular APD90. The frequency of spontaneous sarcoplasmic reticulum Ca2+ sparks and waves were reduced in SCN10A-KO iPSC-CM and control cells following the pharmacological inhibition of NaV1.8. We further analyzed potential triggers of arrhythmias and found reduced delayed afterdepolarizations (DAD) in SCN10A-KO iPSC-CM and after the specific inhibition of NaV1.8 in control cells. In conclusion, we show that NaV1.8-induced INaL primarily impacts arrhythmogenesis at a subcellular level, with minimal effects on systolic cellular Ca2+ release. The inhibition or knockout of NaV1.8 diminishes proarrhythmic triggers in ventricular CM. In conjunction with our previously published results, this work confirms NaV1.8 as a proarrhythmic target that may be useful in an anti-arrhythmic therapeutic strategy.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper aims to explore the specific contribution of sodium channel Na V1.8 to the occurrence of arrhythmia in human ventricular cardiomyocytes (CM). Specifically, researchers used the induced pluripotent stem cell - cardiomyocyte (iPSC - CM) model through pharmacological inhibition and gene knockout (KO) methods to evaluate the role of Na V1.8 in ventricular arrhythmia. ### Main research questions: 1. **The influence of Na V1.8 on the late sodium current (I NaL)**: Researchers verified the role of Na V1.8 in isoproterenol (Iso) - enhanced I NaL in human ventricular iPSC - CM. Through the specific Na V1.8 blocker PF - 01247324 or gene knockout, a significant reduction in I NaL was observed. 2. **The influence of Na V1.8 on the action potential duration (APD)**: Through the whole - cell patch - clamp technique, researchers found that pharmacological inhibition or gene knockout of Na V1.8 had no significant effect on APD. 3. **The influence of Na V1.8 on arrhythmia - triggering factors**: Researchers further explored the influence of Na V1.8 on spontaneous arrhythmia - triggering factors, such as the frequency of spontaneous sarcoplasmic reticulum (SR) calcium sparks (Ca2+ sparks) and calcium waves (Ca2+ waves). The results showed that pharmacological inhibition or gene knockout of Na V1.8 significantly reduced the frequency of these triggering factors. 4. **The influence of Na V1.8 on delayed after - depolarizations (DADs)**: In the case of increasing intracellular SR calcium stores, researchers observed that pharmacological inhibition or gene knockout of Na V1.8 significantly reduced the occurrence frequency of DADs, thereby reducing the risk of arrhythmia. ### Research methods: - **Gene editing**: Use CRISPR/Cas9 technology to knockout the SCN10A gene in iPSC - CM. - **Pharmacological inhibition**: Use the specific Na V1.8 blocker PF - 01247324. - **Electrophysiological experiments**: Record I NaL and APD through voltage - clamp and current - clamp techniques. - **Fluorescence imaging**: Use Fluo 4 - AM and Fura 2 - AM for calcium imaging to observe the frequency of SR calcium sparks and calcium waves. ### Conclusions: The research results indicate that Na V1.8 mainly affects the occurrence of arrhythmia at the subcellular level by generating I NaL, while having a relatively small impact on systolic intracellular calcium release. Inhibition or knockout of Na V1.8 can significantly reduce arrhythmia - triggering factors, such as SR calcium sparks, calcium waves, and DADs, thereby reducing the risk of arrhythmia. These findings provide important evidence for Na V1.8 as a potential target for anti - arrhythmia treatment.

NaV1.8 as Proarrhythmic Target in a Ventricular Cardiac Stem Cell Model

Molecular and Functional Relevance of NaV1.8-Induced Atrial Arrhythmogenic Triggers in a Human SCN10A Knock-Out Stem Cell Model

Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart

Patient-specific Ipsc-Derived Cardiomyocytes Reveal Aberrant Activation of Wnt/β-catenin Signaling in SCN5A-related Brugada Syndrome

P1596Interaction of CaMKII and NaV1.8 modulates cardiac electrophysiology in human heart failure

Altered firing activity of intracardiac neurons isolated from mice carrying the Scn5a-1798insD mutation

Exploring SCN5A variants associated with atrial fibrillation in atrial cardiomyocytes derived from human induced pluripotent stem cells: A characterization study

Biophysical properties of NaV1.5 channels from atrial-like and ventricular-like cardiomyocytes derived from human induced pluripotent stem cells

NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment

Blockade Of Na-V1.8 Increases The Susceptibility To Ventricular Arrhythmias During Acute Myocardial Infarction

Variant Intronic Enhancer Controls SCN10A-short Expression and Heart Conduction

Blockade of Na<sub>V1</sub>.8 Increases the Susceptibility to Ventricular Arrhythmias During Acute Myocardial Infarction

Abstract 17032: Substrate Stiffness Alters the Kinetics of Sodium Channel Nav1.5 and Depolarization of Cardiomyocytes

Gene Therapy with the N-terminal Fragment of Nav1.5 for Cardiac Channelopathies: A Novel Transcomplementation Mechanism Potentiating the Cardiac Sodium Current

Epilepsy-associated Kv1.1 channel subunits regulate intrinsic cardiac pacemaking in mice

Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC–derived atrial fibrillation model

The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies

Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy

The Kir2.1-Na V 1.5 Channelosome and its role in Arrhythmias in Inheritable Cardiac Diseases

SNTA1 Gene Rescues Ion Channel Function in Cardiomyocytes Derived from Induced Pluripotent Stem Cells Reprogrammed from Muscular Dystrophy Patients with Arrhythmias

The cardiac sympathetic co-transmitter neuropeptide-Y is pro-arrhythmic in human cardiomyocytes by lengthening activation-recovery interval